Leadership Overview
Bliss GVS Pharma has 5 executives leading key functions including financial strategy, global marketing, and production coordination.
Committed to enhancing global well-being through accessible healthcare, Bliss GVS Pharma drives innovation in pharmaceutical manufacturing to deliver high-quality capsules, creams, and specialized suppositories to international markets.
Committed to enhancing global well-being through accessible healthcare, Bliss GVS Pharma drives innovation in pharmaceutical manufacturing to deliver high-quality capsules, creams, and specialized suppositories to international markets.
Leadership Roles at Bliss GVS Pharma
Deepak Sawant - Chief Financial Officer
Deepak Sawant, the Chief Financial Officer at Bliss GVS Pharma, directs all fiscal operations and capital allocation strategies. Overseeing the financial health of the organization, the Chief Financial Officer ensures rigorous compliance with international accounting standards while supporting the expansion of manufacturing facilities. This leadership role involves managing investor relations and optimizing the cost structure for the production of capsules, creams, and injections. By implementing robust financial controls, Deepak Sawant directly impacts the long-term sustainability of the company. Sawant secures the necessary funding for research and development initiatives, enabling the firm to maintain a competitive edge in the global pharmaceutical market. Through precise budgetary oversight, the Chief Financial Officer facilitates the scaling of operations across diverse geographic regions, ensuring that the company remains a leader in the manufacturing of suppositories and pessaries while delivering consistent value to stakeholders.
Aditi More - Senior Executive, Chief Marketing Officer
Aditi More, the Senior Executive, Chief Marketing Officer at Bliss GVS Pharma, architects the global brand strategy and market positioning for the entire pharmaceutical portfolio. Overseeing the outreach to healthcare providers, the Senior Executive, Chief Marketing Officer ensures that the company's mission of accessibility reaches key international markets. This leadership role involves analyzing market trends to identify new opportunities for the distribution of specialized healthcare items. By crafting targeted campaigns, Aditi More directly impacts the adoption of the company's products among medical professionals. More drives the expansion of the brand footprint, focusing on high-growth regions where the demand for effective pharmaceutical solutions remains critical. Through strategic partnerships and clear communication of product efficacy, the Senior Executive, Chief Marketing Officer strengthens the market presence of the firm, ensuring that the company remains the preferred choice for reliable and effective pharmaceutical solutions worldwide.
Sampat Jondhale - Manager Chief Marketing Officer
Sampat Jondhale, the Manager Chief Marketing Officer at Bliss GVS Pharma, executes regional marketing initiatives and manages the tactical deployment of product launches. Overseeing the day-to-day engagement with local distributors, the Manager Chief Marketing Officer ensures that the company's diverse range of injections and healthcare items meets specific regional regulatory requirements. This leadership role involves coordinating with sales teams to maximize the penetration of the company's product line in emerging markets. By refining the promotional strategy for specific product categories, Sampat Jondhale directly impacts the revenue growth within these territories. Jondhale monitors competitive activity to adjust marketing tactics in real-time, maintaining the company's reputation for quality and efficiency. Through consistent interaction with regional stakeholders, the Manager Chief Marketing Officer supports the broader organizational goal of increasing the accessibility of pharmaceuticals while ensuring that the company's unique value proposition remains clear and compelling.
Vidula Ranade - Executive- Chief Marketing Officer
Vidula Ranade, the Executive- Chief Marketing Officer at Bliss GVS Pharma, directs the digital transformation of marketing channels and customer engagement platforms. Overseeing the integration of data-driven insights into the sales process, the Executive- Chief Marketing Officer ensures that the company effectively communicates the benefits of its world-class manufacturing capabilities. This leadership role involves developing comprehensive strategies for the promotion of the company's specialized suppositories and pessaries. By leveraging digital tools to reach a broader audience of healthcare consumers, Vidula Ranade directly impacts the brand's visibility and market share. Ranade collaborates with cross-functional teams to align marketing efforts with the company's overarching mission of enhancing well-being. Through the implementation of innovative communication strategies, the Executive- Chief Marketing Officer fosters stronger relationships with global healthcare partners, ensuring that the company remains at the forefront of the pharmaceutical industry's digital evolution.
Vijay Dalavi - Executive Chief Marketing Officer & Production Coordinator
Vijay Dalavi, the Executive Chief Marketing Officer & Production Coordinator at Bliss GVS Pharma, bridges the gap between market demand and manufacturing output. Overseeing the synchronization of production schedules with marketing forecasts, the Executive Chief Marketing Officer & Production Coordinator ensures that the company maintains optimal inventory levels for its wide range of pharmaceutical products. This leadership role involves managing the supply chain logistics to guarantee the timely delivery of capsules and injections to international clients. By aligning production capacity with the strategic goals of the marketing department, Vijay Dalavi directly impacts the operational efficiency of the firm. Dalavi coordinates with facility managers to ensure that quality standards remain high during periods of increased demand. Through this dual focus on production and market alignment, the Executive Chief Marketing Officer & Production Coordinator supports the company's mission to provide reliable pharmaceutical solutions while maximizing the output of world-class manufacturing facilities.
Explore Leadership Teams in Manufacturing
SOHO Global Health is a pioneer in natural herbal-based medicine, focusing on innovative herbal research and the development of high-quality health products. Their product range includes immune boosters, children's multivitamins, and supplements aimed at improving overall health and wellness. The company is committed to harnessing Indonesia's natural resources and indigenous plants to enhance the health of its customers. SOHO Global Health aims to create positive societal impacts through strategic partnerships and a customer-centric approach.
Company Leadership RL
HS
PB
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Company Leadership
CC
SR
Founded in 1974, New England BioLabs is a privately held company that produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology, and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase. The company is headquartered in Ipswitch, Massachusetts.
Company Leadership SR
LB
Getz Pharma is an international research-driven, branded generic pharmaceutical company specializing in the formulation, development, manufacturing and marketing of a wide range of quality, affordable medicines.
Company Leadership
HA
AS
MB
Frequently Asked Questions Regarding Bliss GVS Pharma Top Executives and Leadership Team
